Pancreatic enucleation using the da Vinci robotic surgical system: a report of 26 cases

• DOI: 10.1002/rcs.1719
• Publication Date: 2015-12-18T09:55:35Z
• Authors: Yusheng Shi; Chenghong Peng; Baiyong Shen; Xiaxing Deng; Jiabin Jin; Zhichong Wu; Qian Zhan; Hongwei Li
• Keywords: Serous Cystadenoma

Abstract Background As a tissue‐sparing procedure, pancreatic enucleation has become an alternative for benign or borderline tumours; it been proved to be safe and feasible. To date, large sample size of robotic not reported. This study aimed discuss the clinical evaluation postoperative complications after compare with open surgery. Methods Patients who underwent during December 2010–December 2014 at Shanghai Ruijin Hospital, affiliated Jiaotong University School Medicine in China, were included. Clinical data collected analysed. Results divided into group group: 26 patients enucleation, whom 13 female. The mean age was 51.7 years, operation time 125.7 ± 58.8 min, blood loss 49.4 33.4 ml tumour 18.8 7.9 mm; 17 11 54.6 17.2 198.5 70.7 3.5 1.9 cm. Pathology included insulinomas, intrapancreatic mucinous neoplasmas (IPMNs), neuro‐endocrine tumours (PNETs), solid pseudopapillary (SPTs) serous cystadenomas (SCAs). Robotic enucleations associated less trauma, shorter time, faster wound recovery compared enucleation. Pancreatic fistulas (PFs) main complication that occurred group; infection also group. All recovered effective drainage use somatostatin. follow‐up 25 months. No recurrence discovered, one patient suffered endocrine insufficiency. Conclusion is surgical procedure tumours. It produces trauma than might extend indications PF rate surgery still high long‐term needs performed. Copyright © 2015 John Wiley & Sons, Ltd.